Orient Pharma Co., Ltd. (4166.TWO)

TWD 30.0

(-1.48%)

Net Income Summary of Orient Pharma Co., Ltd.

  • Orient Pharma Co., Ltd.'s latest annual net income in 2023 was 22.28 Million TWD , up 177.5% from previous year.
  • Orient Pharma Co., Ltd.'s latest quarterly net income in 2024 Q2 was 48.5 Million TWD , down 0.0% from previous quarter.
  • Orient Pharma Co., Ltd. reported an annual net income of -28.75 Million TWD in 2022, up 71.98% from previous year.
  • Orient Pharma Co., Ltd. reported an annual net income of -102.65 Million TWD in 2021, up 40.1% from previous year.
  • Orient Pharma Co., Ltd. reported a quarterly net income of 48.5 Million TWD for 2024 Q2, down 0.0% from previous quarter.
  • Orient Pharma Co., Ltd. reported a quarterly net income of 11.04 Million TWD for 2023 Q4, down 0.0% from previous quarter.

Annual Net Income Chart of Orient Pharma Co., Ltd. (2023 - 2019)

Historical Annual Net Income of Orient Pharma Co., Ltd. (2023 - 2019)

Year Net Income Net Income Growth
2023 22.28 Million TWD 177.5%
2022 -28.75 Million TWD 71.98%
2021 -102.65 Million TWD 40.1%
2020 -171.37 Million TWD 14.75%
2019 -201.02 Million TWD 0.0%

Peer Net Income Comparison of Orient Pharma Co., Ltd.

Name Net Income Net Income Difference
Allied Biotech Corporation 97.41 Million TWD 77.12%
GeneFerm Biotechnology Co., Ltd. 124.62 Million TWD 82.115%
Easywell Biomedicals, Inc. -144.81 Million TWD 115.39%
TTY Biopharm Company Limited 1.12 Billion TWD 98.025%
Synmosa Biopharma Corporation 594.83 Million TWD 96.253%
Orient EuroPharma Co., Ltd. 143.94 Million TWD 84.516%
Center Laboratories, Inc. -995.42 Million TWD 102.239%
Tien Liang BioTech Co., Ltd. 17.73 Million TWD -25.694%
InnoPharmax Inc. -70.83 Million TWD 131.466%
Johnson Chemical Pharmaceutical Works Co., Ltd. 79.7 Million TWD 72.035%
Excelsior Biopharma Inc. -91.01 Million TWD 124.489%
DV Biomed Co., Ltd. 162.91 Million TWD 86.319%
Foresee Pharmaceuticals Co., Ltd. -1.03 Billion TWD 102.151%
Handa Pharmaceuticals, Inc. 726.88 Million TWD 96.934%
UniPharma Co., Ltd. -21.81 Million TWD 202.178%
Anxo Pharmaceutical Co., Ltd. 21.86 Million TWD -1.953%
Alar Pharmaceuticals Inc. 382.61 Million TWD 94.175%
Winston Medical Supply Co., Ltd. 158.75 Million TWD 85.961%
Mercury Biopharmaceutical Corporation -43.81 Million TWD 150.867%
Bioray Biotech Co., Ltd -11.55 Million TWD 292.819%
TSH Biopharm Corporation Limited 61.98 Million TWD 64.045%